@WHO: Interim results from the Solidarity Therapeutics Trial, coordinated by WHO, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir & interferon regimens appeared to have little or no effect on mortality or reduction in hospital stays for #COVID19 patients. https://t.co/eNoW6HL0y3

http://twitter.com/WHO
via IFTTT